The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes
Radhia M’kacher(Genopole (France)), Patrice Carde(Institut Gustave Roussy), Monika Frenzel(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Olivier Moralès(Centre National de la Recherche Scientifique), Claire Borie(Inserm), William M. Hempel, T. Girinsky(Institut Gustave Roussy), Luc Morat(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Leonhard Heidingsfelder(Robert Bosch (Germany)), Bruno Colicchio(Université de Haute-Alsace), Sarah Renaud(Centre National de la Recherche Scientifique), Corina Cuceu(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Noufϊssa Oudrhiri(Inserm), Grace Shim(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Mustafa Al Jawhari(Direction de la Recherche Fondamentale), Annelise Bennaceur‐Griscelli(Inserm), Zoé Van de Wyngaert(Centre Hospitalier Universitaire de Lille), Éric Jeandidier(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Alain Dieterlen(Université de Haute-Alsace), Nadira Delhem(Inserm), Steffen Junker(Aarhus University), Aude Lenain(Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Cited by 22
Related Papers
Eight Cycles of ABVD Versus Four Cycles of BEACOPP<sub>escalated</sub>Plus Four Cycles of BEACOPP<sub>baseline</sub>in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial
|Journal of Clinical Oncology|2016|121
Serum 2-Hydroxyglutarate Production in <i>IDH1</i>- and <i>IDH2</i>-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
|Journal of Clinical Oncology|2013|117
A High Frequency of Y Chromosome Deletions in Males with Nonidiopathic Infertility<sup>1</sup>
|The Journal of Clinical Endocrinology & Metabolism|1999|93
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
|Frontiers in Oncology|2019|80